JP2021511374A5 - - Google Patents
Info
- Publication number
- JP2021511374A5 JP2021511374A5 JP2020560532A JP2020560532A JP2021511374A5 JP 2021511374 A5 JP2021511374 A5 JP 2021511374A5 JP 2020560532 A JP2020560532 A JP 2020560532A JP 2020560532 A JP2020560532 A JP 2020560532A JP 2021511374 A5 JP2021511374 A5 JP 2021511374A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydrocarbon
- heterocyclic
- stereoisomer
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810044308.4 | 2018-01-17 | ||
| CN201810044308.4A CN110041327B (zh) | 2018-01-17 | 2018-01-17 | 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用 |
| CN201811517425.4A CN111303147B (zh) | 2018-12-12 | 2018-12-12 | 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用 |
| CN201811517425.4 | 2018-12-12 | ||
| PCT/CN2019/071902 WO2019141179A1 (zh) | 2018-01-17 | 2019-01-16 | 吡啶酮衍生物、其组合物及作为抗流感病毒药物的应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021511374A JP2021511374A (ja) | 2021-05-06 |
| JP2021511374A5 true JP2021511374A5 (enExample) | 2022-03-15 |
| JP7352297B2 JP7352297B2 (ja) | 2023-09-28 |
Family
ID=67301986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560532A Active JP7352297B2 (ja) | 2018-01-17 | 2019-01-16 | ピリドン誘導体と、その組成物、並びにそれらが抗ウイルス薬物としての応用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11247993B2 (enExample) |
| EP (1) | EP3753936B1 (enExample) |
| JP (1) | JP7352297B2 (enExample) |
| KR (1) | KR102477187B1 (enExample) |
| CN (4) | CN111848615B (enExample) |
| AU (1) | AU2019210414B2 (enExample) |
| CA (1) | CA3088926A1 (enExample) |
| PH (1) | PH12020551264A1 (enExample) |
| SG (1) | SG11202011447UA (enExample) |
| WO (1) | WO2019141179A1 (enExample) |
| ZA (1) | ZA202007143B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2881776T3 (es) | 2016-03-08 | 2021-11-30 | Novartis Ag | Compuestos tricíclicos útiles para tratar las infecciones por ortomixovirus |
| JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
| CN111386276B (zh) | 2017-10-06 | 2023-06-23 | 盐野义制药株式会社 | 制备取代的多环吡啶酮衍生物的立体选择性方法 |
| CN118878544A (zh) * | 2018-02-28 | 2024-11-01 | 诺华股份有限公司 | 作为正粘病毒复制抑制剂用于治疗流感的化合物 |
| CN112118891B (zh) * | 2019-04-01 | 2023-10-31 | 尼坎医疗公司 | 作为流感病毒复制抑制剂的稠和多环吡啶酮化合物 |
| CN111909174B (zh) * | 2019-05-08 | 2022-01-21 | 江西彩石医药科技有限公司 | 吡啶酮衍生物的晶型及制备方法和应用 |
| CN112574170A (zh) * | 2019-09-29 | 2021-03-30 | 江西东邦药业有限公司 | 一种二苯并七元环衍生物及其制备方法和应用 |
| WO2021129602A1 (zh) * | 2019-12-23 | 2021-07-01 | 石家庄迪斯凯威医药科技有限公司 | 取代的多环化合物及其药物组合物和用途 |
| CN113045589B (zh) * | 2019-12-27 | 2024-08-23 | 广东东阳光药业股份有限公司 | 流感病毒复制抑制剂及其用途 |
| CN112898346B (zh) * | 2020-01-23 | 2023-11-10 | 南京知和医药科技有限公司 | 水溶性多环化合物及其药物组合物和用途 |
| CN113116899B (zh) * | 2020-03-06 | 2022-12-20 | 广东众生睿创生物科技有限公司 | 一种用于治疗流感的药物组合物及含有该药物组合物的制剂 |
| CN111943879A (zh) * | 2020-08-03 | 2020-11-17 | 南通大学 | 一种（3s，4r）3-氨基-4（甲氧基甲基）吡咯烷-1-甲酸叔丁酯及其合成方法 |
| CN113583022B (zh) * | 2020-08-11 | 2025-03-18 | 石家庄迪斯凯威医药科技有限公司 | 多环化合物及其药物组合物和用途 |
| CN115385932A (zh) * | 2021-05-22 | 2022-11-25 | 江西彩石医药科技有限公司 | 吡啶酮衍生物的中间体及其制备方法 |
| KR20250078466A (ko) * | 2022-10-08 | 2025-06-02 | 스자좡 디스커버리 메디슨 테크놀로지 컴퍼니 리미티드 | 인플루엔자 바이러스 억제 유도체 및 그 용도 |
| CN117003771B (zh) * | 2022-11-09 | 2024-02-02 | 石家庄迪斯凯威医药科技有限公司 | 一种抗流感病毒衍生物及其用途 |
| CN116789556A (zh) * | 2023-05-26 | 2023-09-22 | 康化（上海）新药研发有限公司 | 一种含环丙氧基乙胺的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8927710B2 (en) | 2009-06-15 | 2015-01-06 | Shionogi & Co., Ltd. | Substituted polycyclic carbamoylpyridone derivative |
| DK2620436T3 (en) | 2010-09-24 | 2018-07-30 | Shionogi & Co | Substituted polycyclic carbamoylpyridone derivative prodrug |
| MX377396B (es) * | 2013-09-12 | 2025-03-10 | Janssen Biopharma Inc | Compuestos de azapiridona y usos de los mismos. |
| SG11201708721XA (en) | 2015-04-28 | 2017-11-29 | Shionogi & Co | Substituted polycyclic pyridone derivative and prodrug thereof |
| SG11201804348SA (en) * | 2015-12-15 | 2018-06-28 | Shionogi & Co | Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug |
| JP6806413B2 (ja) * | 2016-02-03 | 2021-01-06 | 塩野義製薬株式会社 | 多環性ピリドン誘導体およびそのプロドラッグ |
| KR20190018469A (ko) * | 2016-08-10 | 2019-02-22 | 시오노기세야쿠 가부시키가이샤 | 치환된 다환성 피리돈 유도체 및 그의 프로드러그를 함유하는 의약 조성물 |
| JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
-
2019
- 2019-01-16 US US16/487,088 patent/US11247993B2/en active Active
- 2019-01-16 SG SG11202011447UA patent/SG11202011447UA/en unknown
- 2019-01-16 EP EP19741336.2A patent/EP3753936B1/en active Active
- 2019-01-16 WO PCT/CN2019/071902 patent/WO2019141179A1/zh not_active Ceased
- 2019-01-16 AU AU2019210414A patent/AU2019210414B2/en active Active
- 2019-01-16 CN CN202010817434.6A patent/CN111848615B/zh active Active
- 2019-01-16 CN CN202010817435.0A patent/CN111848616B/zh active Active
- 2019-01-16 KR KR1020207023803A patent/KR102477187B1/ko active Active
- 2019-01-16 CN CN202010817035.XA patent/CN111848614B/zh active Active
- 2019-01-16 CA CA3088926A patent/CA3088926A1/en active Pending
- 2019-01-16 CN CN201980000078.4A patent/CN110637016B/zh active Active
- 2019-01-16 JP JP2020560532A patent/JP7352297B2/ja active Active
-
2020
- 2020-08-17 PH PH12020551264A patent/PH12020551264A1/en unknown
- 2020-11-16 ZA ZA2020/07143A patent/ZA202007143B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021511374A5 (enExample) | ||
| ES2927777T3 (es) | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP | |
| RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| RU2428428C2 (ru) | Серусодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с | |
| JP2006515858A5 (enExample) | ||
| TW313565B (enExample) | ||
| CA2405521A1 (en) | Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties | |
| JP2022506887A5 (enExample) | ||
| CA2422377A1 (en) | Pyrazole compounds useful as protein kinase inhibitors | |
| ES2243441T3 (es) | Derivados de imidazolio fundidos. | |
| EA201991684A1 (ru) | Аналоги атазанавира (atv) для лечения вич-инфекций | |
| RU2014140739A (ru) | Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения | |
| JP2021501756A5 (enExample) | ||
| EA200501326A1 (ru) | Пиримидины и триазины, ингибирующие репликацию вич | |
| TW200745029A (en) | Sulfonamide derivatives exhibiting PGD2 receptor antagonism | |
| AR099367A1 (es) | Inhibidores de la tirosina quinasa de bruton | |
| EA201650029A1 (ru) | Пиразолопиридины и пиразолопиримидины | |
| AR080878A1 (es) | Derivados heterociclicos de ariletinilo, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos en el tratamiento de la esquizofrenia y trastornos cognitivos. | |
| AR064319A1 (es) | Compuestos y composiciones farmaceuticas derivadas de sulfonamida ciclicos, proceso de preparacion y usos en el tratamiento de trastornos vasomotrices, sexuales, gastrointestinales y otros | |
| CA2475432A1 (en) | 2,4,6-triamino-1,3,5-triazine derivative | |
| HRP20180081T1 (hr) | Fuzionirani triciklični heterociklični spojevi kao inhibitori hiv integraze | |
| CA2565852C (en) | 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands | |
| HRP20212020T1 (hr) | Derivati parazola zgušenog prstena i njihova priprema i njihova primjena u liječenju raka, upale i imunoloških bolesti | |
| HRP20220479T1 (hr) | Spojevi |